Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antibiotic
glycopeptide antibiotic |
| gptkbp:ATCCode |
J01XA02
|
| gptkbp:CASNumber |
61036-62-2
|
| gptkbp:component |
gptkb:teicoplanin
|
| gptkbp:hasMolecularFormula |
C88H97Cl2N9O33
|
| https://www.w3.org/2000/01/rdf-schema#label |
teicoplanin A2II
|
| gptkbp:IUPACName |
(2S,3R,4S,5S,6R)-2-[(2S,3R,4S,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol derivative
|
| gptkbp:mechanismOfAction |
inhibits bacterial cell wall synthesis
|
| gptkbp:producedBy |
Actinoplanes teichomyceticus
|
| gptkbp:routeOfAdministration |
intramuscular
intravenous |
| gptkbp:usedFor |
treatment of Gram-positive bacterial infections
|
| gptkbp:bfsParent |
gptkb:CHEBI:65309
|
| gptkbp:bfsLayer |
7
|